Embolotherapy blocks arteries with an object (such as an inserted balloon catheter) to control or prevent untreatable bleeding. This method is used to control bleeding and reduce tumors, and it is an endovascular treatment aimed at sealing off abnormal blood vessels to control bleeding. Embolotherapy plays a major role in managing pelvic tract bleeding, postpartum adjustment, and the management of cervical pregnancy. This therapy helps treat iatrogenic solid organs, vascular injuries, and the non-surgical treatment of organ trauma, including the liver, spleen, and kidneys. Embolotherapy improves enlarged uterine fibroids, preoperative devascularization of tissues and organs, and obliteration of duodenal variceal. This requires selecting an embolization agent with the desired permanence of the vascular occlusion.
Cook Medical LLC and Boston Scientific Corporation – Notable Market Players in Embolotherapy Market
Market leaders operating in the market have undertaken various organic growth strategies in the embolotherapy market. Some relevant players in embolotherapy market include Abbott, Boston Scientific Cook Medical, Terumo Corporation, and Guerbet. The companies have been implementing various strategies that have helped the company’s growth and, in turn, have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies, including mergers and acquisitions, partnerships, and collaboration.
Below is the list of the growth strategies done by the players operating in the embolotherapy market:
| Company | Month & Year | Category | Description |
| Abbott | Sep-2021 | Expansion | Abbott expands peripheral vascular offerings with the acquisition of walk Vascular, LLC |
| Cook Medical | Feb-2020 | Product Launch | Cook Medical announced the launch of a new customer portal to provide an enhanced digital and self-service customer experience. |
| Boston Scientific | Apr-2022 | Product News | Boston Scientific Receives FDA Clearance for the EMBOLD Fibered Detachable Coil |
| Guerbet | Mar-2022 | Product Launch | Guerbet expands its portfolio with microcatheters and guidewires for interventional imaging and embolization |
| Terumo Corporation | Jul-2021 | Product Launch | Terumo Introduces New AZUR Vascular Plug and PG Pro Peripheral Microcatheter Embolization System |
